General Information of This Metabolic Reaction (MR) (ID: MR006351)
Formula
SVG example
Reactant Ginsenoside Rh2 Product 20(S)-protopanaxadiol
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006350 Ginsenoside Rh2 20(R)-protopanaxadiol Unclear Ginsenoside Rh2 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006457 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol 20(S)-protopanaxadiol Unclear SC-46553 [2]
MR006980 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol 20(S)-protopanaxadiol Unclear HY-N0040 [2]
References
1 Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation
2 Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull. 2000 Dec;23(12):1481-5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.